Clinical Trials for Unresectable Digestive System Neuroendocrine Tumor G2

Find clinical trials for unresectable digestive system neuroendocrine tumor g2. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

NCT ID: NCT05773274

The NET RETREAT Trial is a clinical study aimed at comparing two different treatments for patients with metastatic midgut neuroendocrine tumors (NET) that cannot be surgically removed. The trial is...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Detroit, Michigan, United States +27 more

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

NCT ID: NCT07150546

This clinical trial is studying a new way to treat large neuroendocrine tumors in the digestive system that cannot be removed by surgery. The treatment combines two types of therapy: a precise form...

Not yet recruiting

Phase: PHASE1 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions